Comprehensive
Heart Health Analytics
for Greater Longevity
Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events
We deliver a holistic approach to prevent heart disorders for elevated risk groups, using innovative and clinically proven machine-learning algorithms
Monitor
Cloud solution for affordable real-time remote heart health monitoring through any leads digital ECG device integration
Analyze
Clinically proven machine-learning algorithms that analyze up to 400 vital ECG parameters and detect all types of Arrythmias, Atrial Fibrillation, Myocardial Infarction, Ventricular Hypertrophy
Predict
Patent-pending Universal ECG and Personal Baseline Scores to precisely predict heart attacks and strokes up to 2 months before they occur
Prevent
Personalized reports on vital cardiac parameters values to timely adjust medication and patient's lifestyle, increasing access to preventive care
Remote Real-time Heart Health Monitoring
Allows to accurately determine the position of every cardiac parameter on a scale from a personal baseline to pathology to prevent dangerous heart events for elevated risk groups
Diabetes Cardiovascular Comorbidities Prevention
Provides an integrated solution for primary prevention of cardiovascular complications in diabetes with specific cardiac parameters monitoring, timely disease CVD risk detection and cure
Fatigue Risk Management
Comprehensive liability insurance solution and alert system for seamless real-time fatigue risks monitoring in critical safety job performers to prevent further accidents
Benefits
for corporate sector
Comprehensive clinically-proven and CE-certified, yet affordable tracking of all-known vital parameters to ease and speed-up the patient diagnosticating for cardiologists, general practitioners and healthcare providers
Healthcare system cost burden reduction, driven by eliminated physician office visits, dangerous heart events and hospital readmission prevention with timely cardiovascular risk detection and early treatment intervention
Plain, patient- and doctor-adapted visually compelling cardiac health reports, enabling patients to take control of and positively impact their health with necessary lifestyle adjustments
Team
Meet our health passionate and expert global team, standing behind the Cardiolyse platform development and growth
Advisory Board
Pulli Global Development Advisor Executive with 25+ years of experience in Business Development (ex-CEO Chiezi)
Pirttiaho Global Development Advisor MedTech solutions growth expert with 15+ years in sales for large and small ventures
Gualerzi Scientific Advisor Experienced medical director and cardiologist, leading non-profit's and corporate scientific divisions
News
Microsoft for Startups $120K Azure Sponsorship Offer Received
As a member of the Microsoft for Startups program, we’re excited and thankful for the additional $90K Azure Sponsorship offer, $120K in total, that we received today. The program is dedicated to bringing technical and business support to help entrepreneurs tackling the world’s toughest challenges quickly bring their innovative solutions to those in need across Healthcare, Sustainability, and Accessibility. It’s […]
Read more
Cardiolyse has been accepted to the OpenAPI Bootcamp
Cardiolyse has been accepted onto the OpenAPI Bootcamp on cross-market integration for digital health. TheHill, a part of the Oxford University Hospitals NHS Foundation Trust in collaboration with Region Skane (Sweden) and Trinity College (Dublin) provides a 6-week training program designed to support early-stage startups and SME focused on digital health. The 10 selected teams of MSc, MDs, patients, as […]
Read more
Cardiolyse is selected for the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma event
To match innovators with a task force of experts to develop commercially-viable products and services with the greatest potential for societal and economic impact in Europe this time European Institute of Innovation and Technology (EIT Health) joined forces with Amgen, Bayer, Beiersdorf AG, and Boehringer Ingelheim. AMGEN, one of the world’s leading biotechnology companies, aimed at finding the solution to […]
Read more
Cardiolyse has won $50K in funding from Ukrainian Startup Fund
Exciting news during these challenging times!Cardiolyse has received the $50K grant from Ukrainian Startup Fund. Our co-founder and CEO, Anna Starynska has presented the company during the USF online Pitching Session and scored one of the highest ranks. The 6th batch of the Ukrainian Startup Fund (USF) competition was represented by 18 great startups operating in various fields from logistics […]
Read more
Cardiolyse Cardiac Analytics solution in COVID-19 Disruptive circumstances
Cardiolyse aims to support the high-risk groups’ cardiac health monitoring and management in Coronavirus pandemic circumstances At the disruptive times with the COVID-19 outbreak growing Cardiolyse is all-hands ready to expand the availability of our platform and deliver the solution to those of high cardiac risk and elderly people currently isolated at home or restricted from safe & easy medical […]
Read moreSend us a word regarding any question or suggestion you have
Let’s work together
on heart health improvement